Histone methylation changes of H3K9 and H3K36 in PBMCs as pharmacodynamic biomarkers for Zavondemstat (TACH101), a pan-inhibitor of KDM4 histone lysine demethylase

被引：0
|
作者：
Chandhasin, C. [1 ]
Perabo, F. [2 ]
Dai, Y. [3 ]
DiMascio, L. [4 ]
Mehta, R. K. [5 ]
Hassan, M. K. [5 ]
Nyati, M. K. [5 ]
机构：
[1] Tachyon Therapeut, Sci Affairs, Houston, TX USA
[2] Tachyon Therapeut, Med, Houston, TX USA
[3] Tachyon Therapeut, Med, San Francisco, CA USA
[4] Tachyon Therapeut, Clin Operat, Houston, TX USA
[5] Univ Michigan, Radiat Oncol, Ann Arbor, MI 48109 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 211卷
关键词：
D O I：
10.1016/j.ejca.2024.114763
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PB233
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [1] Identification of pharmacodynamic and sensitivity biomarkers for TACH101, a pan-inhibitor of KDM4 histone lysine demethylase
    Perabo, Frank
    Yoo, Sanghee
    Chandhasin, Chandtip
    Del Rosario, Joselyn
    Chen, Young K.
    Filvaroff, Ellen
    Stafford, Jeffrey A.
    Quake, Stephen
    Clarke, Michael F.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [2] TACH101, a first-in-class pan-inhibitor of KDM4 histone demethylase
    Chandhasin, Chandtip
    Dang, Van
    Perabo, Frank
    Del Rosario, Joselyn
    Chen, Young K.
    Filvaroff, Ellen
    Stafford, Jeffrey A.
    Clarke, Michael
    ANTI-CANCER DRUGS, 2023, 34 (10) : 1122 - 1131
  • [3] TACH101, a first-in-class pan inhibitor of KDM4 histone lysine demethylases.
    Yoo, Sanghee
    Chandhasin, Chandtip
    Del Rosario, Joselyn R.
    Chen, Young K.
    Stafford, Jeff
    Quake, Stephen
    Perabo, Frank
    Clarke, Michael F.
    CANCER RESEARCH, 2021, 81 (13)
  • [4] Inhibition of histone lysine demethylases with TACH101, a first-in-class pan-inhibitor of KDM4.
    Chandhasin, Chandtip
    Yoo, Sanghee
    Del Rosario, Joselyn
    Chen, Young K.
    Stafford, Jeffrey
    Perabo, Frank
    Clarke, Michael F.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Inhibition of cancer stem cells with TACH101, a first-in-class inhibitor of KDM4 histone lysine demethylase.
    Perabo, Frank
    Chandhasin, Chandtip
    Dang, Van
    Del Rosario, Joselyn
    Chen, Young K.
    Filvaroff, Ellen
    Stafford, Jeffrey
    Quake, Stephen
    Clarke, Michael F.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] Demethylation of histone H3K36 and H3K9 by Rph1:: a vestige of an H3K9 methylation system in Saccharomyces cerevisiae
    Klose, Robert J.
    Gardner, Kathryn E.
    Liang, Gaoyang
    Erdjument-Bromage, Hediye
    Tempst, Paul
    Zhang, Yi
    MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (11) : 3951 - 3961
  • [7] Hairless is a H3K9 histone demethylase
    Liu, L.
    Kim, H.
    Casta, A.
    Luke, C.
    Kobayashi, Y.
    Shapiro, L. S.
    Christiano, A. M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S69 - S69
  • [8] Hairless is a histone H3K9 demethylase
    Liu, Liang
    Kim, Hyunmi
    Casta, Alex
    Kobayashi, Yuki
    Shapiro, Lawrence S.
    Christiano, Angela M.
    FASEB JOURNAL, 2014, 28 (04): : 1534 - 1542
  • [9] Benzo[b]tellurophenes as a Potential Histone H3 Lysine 9 Demethylase (KDM4) Inhibitor
    Kim, Yoon-Jung
    Lee, Dong Hoon
    Choi, Yong-Sung
    Jeong, Jin-Hyun
    Kwon, So Hee
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (23)
  • [10] TACH101, a first-in-class inhibitor of KDM4 histone lysine demethylase for the treatment of diffuse large B-cell lymphoma
    Perabo, Frank
    Chandhasin, Chandtip
    Yoo, Sanghee
    Del Rosario, Joselyn
    Chen, Young K.
    Filvaroff, Ellen
    Stafford, Jeffrey A.
    Quake, Stephen
    Clarke, Michael F.
    CANCER RESEARCH, 2022, 82 (12)
12345